Clinical Trial Update: Observational Study Regarding the Combination of Fluoropyrimidine and Bevacizumab in Patients With mCRC

View source ↗

Summary

This clinical trial update reports on an observational study examining the combination of a fluoropyrimidine and bevacizumab in patients with metastatic colorec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Colon Cancer Metastatic | Status: ACTIVE_NOT_RECRUITING